About drug device combination products
Drug device combination products consist of two regulated components: an active pharmaceutical ingredient and a medical device. These two standardized components are combined, either chemically or physically for developing one component. The drugs present in the device are either impregnated or surface coated. The drug device combination products are considered to be highly innovative in the area of advanced healthcare such as biomedical nanotechnology and development of regenerative medicine.
Technavio's analysts forecast the global drug device combination products market to grow at a CAGR of 11.95% over the period 2014-2019.
Covered in this report
The report includes the present scenario and the growth prospects of the global drug device combination products market for 2015-2019. The market can be segmented by product type:
• Drug eluting stent
• Prefilled syringes
• Wearable injectors
• Insulin delivery systems
Technavio's report, Global Drug Device Combination Products Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global drug device combination products market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
• Americas
• APAC
• EMEA
Key vendors
• Abbott Laboratories
• Becton, Dickinson and Company
• Boston Scientific
• Medtronic
• Roche Diagnostics
Other prominent vendors
• Aerogen
• Airon
• Allied Healthcare Products
• AstraZeneca
• B. Braun Medical
• BIOTRONIK
• Boehringer Ingelheim
• Briggs Healthcare
• C.R. Bard
• Cardinal Health
• Clement Clarke International
• Concordia
• Consort Medical
• Cook Medical
• DeVilbiss Healthcare
• Ethicon
• Gerresheimer
• GlaxoSmithKline
• Heyer Medical
• Invacare
• Lepu Medical Technology
• Mallinckrodt
• Medline Industries
• MicroPort Scientific
• Mylan
• Nypro
• Omron Healthcare
• PARI Medical
• Phillips Healthcare
• RPC Bramlage
• Salter Labs
• Smart inhaler
• Stryker
• Sunovion Pharmaceuticals
• Teleflex
• Terumo
• Vortran Medical
• W. L. Gore & Associates
Key market driver
• Use of home healthcare devices
• For a full, detailed list, view our report
Key market challenge
• High spending by patients
• For a full, detailed list, view our report
Key market trend
• Use of bioabsorable stents
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Offerings of the top vendors
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product
Drug-eluting stents
Prefilled syringes
Wearable injectors
Insulin delivery systems
PART 07: Geographical segmentation
Global drug device combination products market by geographical segmentation
Drug device combination products market in Americas
Drug device combination products market in EMEA
Drug device combination products market in APAC
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 14: Key vendor analysis
Abbott Diagnostics
Becton, Dickinson and Company
Boston Scientific
Medtronic
Roche Diagnostics
PART 15: Appendix
List of abbreviations
PART 16: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global drug device combination products market
Exhibit 03: Global drug device combination products market 2014-2019 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Segmentation of global drug device combination products market by product type
Exhibit 06: Segmentation of global drug device combination products market by product type 2014
Exhibit 07: Segmentation of global drug device combination products market by product type 2019
Exhibit 08: Segmentation of global drug device combination products market by product type 2014-2019
Exhibit 09: Global drug device combination products market in drug-eluting stent segment 2014-2019 ($ billions)
Exhibit 10: Global drug device combination products market in prefilled syringe segment 2014-2019 ($ billions)
Exhibit 11: Global drug device combination products market in wearable injector segment 2014-2019 ($ billions)
Exhibit 12: Global drug device combination products market in insulin delivery system segment 2014-2019 ($ billions)
Exhibit 13: Segmentation of global drug device combination products market by geography 2014
Exhibit 14: Segmentation of global drug device combination products market by geography 2019
Exhibit 15: Segmentation of global drug device combination products market by geography 2014-2019
Exhibit 16: Drug device combination products market in Americas 2014-2019 ($ billions)
Exhibit 17: Diseases and mortality in Europe 2011
Exhibit 18: Drug device combination products market in EMEA 2014-2019 ($ billions)
Exhibit 19: Drug device combination products market in APAC 2014-2019 ($ billions)
Exhibit 20: Impact of drivers
Exhibit 21: Impact of drivers and challenges
Exhibit 22: Companies developing bioabsorbable drug-eluting stents
Exhibit 23: Abbott Diagnostics: Key takeaways
Exhibit 24: BD: Key takeaways
Exhibit 25: Boston Scientific: Key takeaways
Exhibit 26: Medtronic: Key takeaways
Exhibit 27: Roche Diagnostics: Key takeaways
Exhibit 28: BD: Business segmentation 2014 by revenue
Exhibit 29: BD: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 30: BD: Geographical segmentation by revenue 2014
Exhibit 31: Boston Scientific: Business segmentation by revenue 2014
Exhibit 32: Boston Scientific: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 33: Medtronic: Business segmentation by revenue 2015
Exhibit 34: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 35: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 36: Roche Diagnostics: Geographical segmentation by revenue 2014
